6 ms·
My son (now 4yo) was diagnosed with two rare diseases, due to a mutation in a collagen production gene, and at first it wasn't clear if he was ever going to wal
by ricardolopes 5y ago
My son (now 4yo) was diagnosed with two rare diseases, due to a mutation in a collagen production gene, and at first it wasn't clear if he was ever going to walk at all. His life will always be severely impacted.
I feel your pain about wanting more R&D around treatments and potential cures but finding almost nothing because it wouldn't be commercially viable.
My main strategy was trying to contribute with what I know best: software development. The company I joined (lifebit.ai) is building tooling to reduce medical/pharma R&D costs, in an effort to make it economically viable to research diseases that weren't viable before. This is a mission I can get behind and that feels like the best use of my time.
I hope you get to find the best way to have the biggest impact. Good luck!
- halukakin 5y agoThank you. Great job btw, lifebit could do some real good! Same idea for me too. If I can manage to make a clean exit on my existing business, medicine R&D will be where I will spend the rest of my time.
- iamcreasy 5y agoThat's nice! Do you happen to know any US based company that are working on similar objective?
- ricardolopes 5y agoIts competitors DNAnexus and Seven Bridges seem to be US based, or at least report having offices there. But Lifebit is recruiting internationally, and even has a US office now too, so AFAIK it should also be a valid option for US folks.
- iamcreasy 5y agoThanks for the info. Only marketing position is for Lifebit US.